β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study
Purpose. The aim of this study was to assess if use of the β LACTA test (BLT) for extended-spectrum beta-lactamase (ESBL) detection and/or early bacterial identification by mass spectrometry (MALDI-TOF MS) improves therapeutic decision-making when combined with advice from the antimicrobial stewardship team (AMST) for the management of Gram-negative bacillary (GNB) bacteraemia.
Methods. Prospective observational theoretical study that included patients with GNB bacteraemia during a 6-month period. We compared, against the antimicrobial choice of the local AMST as informed of the Gram-stain result, a hypothetical choice, i.e. one AMST would have made had it been informed of the MALDI-TOF MS results only (option H) with the actual choice AMST made after being informed of the combined MALDI-TOF MS and BLT results (option A).
Results/Key findings. A total of 131 episodes of GNB bacteraemia were included. Options H and A led to virtually the same rate of efficient antimicrobial therapy (in 120/131 and 123/131 episodes, respectively, P=0.63). Compared to the gold standard, options H and A did not lead to a significant reduction of carbapenem prescription (9/131, 6/131 and 12/131, P=0.57 and P=0.65, respectively).
Conclusions. Under our test conditions, BLT, when used in conjunction with MALDI-TOF MS and AMST advice, did not allow a significant optimization of the antimicrobial prescription made on the basis AMST advice only. However, the impact of BLT should be evaluated in a population with high prevalence of ESBL-producing Enterobacteriaceae and/or when treatment choices are not made by infectious disease specialists.
ThiébautAC, ArletG, AndremontA, PapyE, SolletJP et al. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother2012; 67:1525–1536 [View Article][PubMed]
European Union, European Union European Centre for Disease Prevention and ControlAntimicrobial resistance surveillance in Europe 2012 Luxembourg: Publications Office of the European Union; 2013
KumarA, EllisP, ArabiY, RobertsD, LightB et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest2009; 136:1237–1248 [View Article][PubMed]
IdelevichEA, GrunewaldCM, WüllenweberJ, BeckerK. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS One2014; 9:e114834 [View Article][PubMed]
VerrokenA, DefournyL, LechgarL, MagnetteA, DelméeM et al. Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. Eur J Clin Microbiol Infect Dis2015; 34:405–413 [View Article][PubMed]
RenvoiséA, DecréD, Amarsy-GuerleR, HuangTD, JostC et al. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. J Clin Microbiol2013; 51:4012–4017 [View Article][PubMed]
CompainF, BensekhriH, RostaneH, MainardiJL, LavollayM. β LACTA test for rapid detection of Enterobacteriaceae resistant to third-generation cephalosporins from positive blood cultures using briefly incubated solid medium cultures. J Med Microbiol2015; 64:1256–1259 [View Article][PubMed]
ClercO, Prod'homG, VogneC, BizziniA, CalandraT et al. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis2013; 56:1101–1107 [View Article][PubMed]
HuangAM, NewtonD, KunapuliA, GandhiTN, WasherLL et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis2013; 57:1237–1245 [View Article][PubMed]
WeissE, ZaharJR, LespritP, RuppeE, LeoneM et al. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin Microbiol Infect2015; 21:649.e1–649.e10 [View Article][PubMed]
BruinsM, OordH, BloembergenP, WolfhagenM, CasparieA et al. Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis2005; 24:305–313 [View Article][PubMed]
LaurentT, HuangTD, BogaertsP, GlupczynskiY. Evaluation of the βLACTA test, a novel commercial chromogenic test for rapid detection of ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates. J Clin Microbiol2013; 51:1951–1954 [View Article][PubMed]
GallahS, DecréD, GenelN, ArletG. The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol2014; 52:3792–3794 [View Article][PubMed]
DefournyL. Evaluation of the βLACTA test for direct detection of resistance to third generation cephalosporin in Enterobacteriaceae and Pseudomonas aeruginosa from positive blood culture bottles. In Interscience Conference on Antimicrobial Agents and Chemotherapy2014
RazaziK, DerdeLP, VerachtenM, LegrandP, LespritP et al. Clinical impact and risk factors for colonization with extended- spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med2012; 38:1769–1778 [View Article][PubMed]
GoodmanKE, LesslerJ, CosgroveSE, HarrisAD, LautenbachE et al. A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase-producing organism. Clin Infect Dis2016; 63:896–903 [View Article][PubMed]
β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study